Imagene

Imagene is an emerging leader in AI-based precision oncology, leveraging AI to profile a broad range of cancer biomarkers from digitized biopsy images within minutes. The company empowers physicians with immediate oncology intelligence, facilitating optimal treatment decisions for more cancer patients. Awarded the 2023 Digital Health Award for “Best Use of AI in HealthTech” and the Technology Leadership Best Practices Award by Frost & Sullivan, Imagene's success derives from its cutting-edge technology and multidisciplinary team of experts dedicated to advancing precision oncology and improving cancer patient care.

For more information, please visit imagene-ai.com

Applications by this vendor

Imagene NSCLC Panel

Research only | H&E

ImageneOI is an AI-based biomarker profiling solution providing rapid NSCLC biomarker status from the H&E biopsy image alone. Currently offering profiling of EGFR mutations and ALK fusions. A biomarker status report is provided within minutes.